Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 09:32 am Purchase |
2024-09-30 | 13G | Heron Therapeutics, Inc. HRTX |
Adage Capital Management L.P. | 8,850,000 5.840% |
8,850,000 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Heron Therapeutics, Inc. HRTX |
BLACKROCK INC BLK |
8,534,567 5.600% |
0 (Unchanged) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Heron Therapeutics, Inc. HRTX |
BLACKROCK INC BLK |
8,534,567 5.600% |
1,497,253 (+21.28%) |
Filing History |
| 2024-05-31 11:08 am Unchanged |
2023-11-14 | 13D | Heron Therapeutics, Inc. HRTX |
Rubric Capital Management LP | 26,713,503 17.700% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:37 pm Sale |
2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
GREAT POINT PARTNERS LLC | 0 0.000% |
-6,360,161 (Position Closed) |
Filing History |
| 2024-02-14 4:21 pm Sale |
2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
Baker Bros. Advisors LP | 7,881,933 4.990% |
-249,745 (-3.07%) |
Filing History |
| 2024-02-14 08:46 am Sale |
2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
Deep Track Capital, LP | 0 0.000% |
-12,232,267 (Position Closed) |
Filing History |
| 2024-02-13 5:06 pm Purchase |
2023-12-29 | 13G | Heron Therapeutics, Inc. HRTX |
The Vanguard Group | 8,338,912 5.560% |
532,627 (+6.82%) |
Filing History |
| 2024-02-06 11:43 am Sale |
2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
FRANKLIN RESOURCES INC BEN |
6,404,795 4.300% |
-5,462,985 (-46.03%) |
Filing History |
| 2023-12-07 2:45 pm Sale |
2023-11-30 | 13G | Heron Therapeutics, Inc. HRTX |
J P MORGAN CHASE & CO JPM |
84,549 0.000% |
-6,669,080 (-98.75%) |
Filing History |
| 2023-12-06 4:47 pm Sale |
2023-11-30 | 13G | Heron Therapeutics, Inc. HRTX |
BLACKROCK INC BLK |
7,037,314 4.700% |
-2,613,395 (-27.08%) |
Filing History |
| 2023-07-25 4:13 pm Purchase |
2023-07-21 | 13D | Heron Therapeutics, Inc. HRTX |
Rubric Capital Management LP | 26,713,503 19.000% |
14,963,503 (+127.35%) |
Filing History |
| 2023-04-13 1:58 pm Purchase |
2022-11-02 | 13G | Heron Therapeutics, Inc. HRTX |
GREAT POINT PARTNERS LLC | 6,360,161 5.350% |
6,360,161 (New Position) |
Filing History |
| 2023-02-22 4:24 pm Unchanged |
2023-02-21 | 13D | Heron Therapeutics, Inc. HRTX |
Rubric Capital Management LP | 11,750,000 9.900% |
0 (Unchanged) |
Filing History |
| 2023-02-14 5:42 pm Sale |
2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
ArrowMark Colorado Holdings LLC | 3,560,848 3.000% |
-2,845,017 (-44.41%) |
Filing History |
| 2023-02-14 4:00 pm Sale |
2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
TANG CAPITAL PARTNERS LP | 3,756,694 3.200% |
-4,026,994 (-51.74%) |
Filing History |
| 2023-02-13 07:29 am Sale |
2022-12-30 | 13G | Heron Therapeutics, Inc. HRTX |
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% |
-8,275,000 (Position Closed) |
Filing History |
| 2023-02-09 11:22 am Sale |
2022-12-30 | 13G | Heron Therapeutics, Inc. HRTX |
The Vanguard Group | 7,806,285 6.570% |
-1,802,760 (-18.76%) |
Filing History |
| 2023-02-06 09:00 am Purchase |
2023-01-25 | 13D | Heron Therapeutics, Inc. HRTX |
Rubric Capital Management LP | 11,750,000 9.900% |
11,750,000 (New Position) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
BLACKROCK INC BLK |
9,650,709 8.100% |
1,968,508 (+25.62%) |
Filing History |